Brief: Chinook Therapeutics Reports First Quarter 2023 Financial Results
09/05/2023 21:21
May 9 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATES
* NET LOSS FOR Q1 OF 2023 WAS $60.2 MILLION, OR $0.85 PER
BASIC
SHARE
* Q1 EARNINGS PER SHARE VIEW $-0.79 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXc4T9Kg
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc